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Abstract Musculoskeletal allografts are typically
disinfected using antibiotics, irradiation or chemical
methods but protocols vary significantly between
tissue banks. It is likely that different disinfection
protocols will not have the same level of microorgan-
ism kill; they may also have varying effects on the
structural integrity of the tissue, which could lead to
significant differences in terms of clinical outcome in
recipients. Ideally, a disinfection protocol should
achieve the greatest bioburden reduction with the
lowest possible impact on tissue integrity. A system-
atic review of three databases found 68 laboratory and
clinical studies that analyzed the microbial bioburden
or contamination rates of musculoskeletal allografts.
The use of peracetic acid–ethanol or ionizing radiation
was found to be most effective for disinfection of
tissues. The use of irradiation is the most frequently
published method for the terminal sterilization of
musculoskeletal allografts; it is widely used and its
efficacy is well documented in the literature. However,
effective disinfection results were still observed using
the BioCleanseTM Tissue Sterilization process, pul-
satile lavage with antibiotics, ethylene oxide, and
chlorhexidine. The variety of effective methods to
reduce contamination rate or bioburden, in conjunc-
tion with limited high quality evidence provides little
support for the recommendation of a single bioburden
reduction method.
Keywords Musculoskeletal allograft  Tissue
donation  Tissue banking  Bioburden
Introduction
Tissue banking is a process in which allografts are
recovered from a donor and stored (banked) for future
use. Prior to storage, the tissue banks process the
tissues to remove microbial contaminants and ensure
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safety of the allografts for transplantation. The allo-
graft is defined as sterile when processes assure no
microorganisms are present to a particular level of
assurance (Vangsness et al. 2006). Disinfection
methods cannot guarantee absolute sterility, but can
achieve a sterility assurance level (SAL). The SAL
represents the probability that a sample will be
contaminated following disinfection (Tenholder
et al. 2003).
Health Canada states that the disinfection of
allografts must be performed, but recommendations
on specific methods or requirements are not published.
Each tissue bank may employ its own method to
disinfect tissue (Health Canada 2013). These methods
are subdivided into ‘disinfection methods,’ and ‘ter-
minal sterilization methods’ (Lambert et al. 2011).
Disinfection methods include chemical and antibiotic
treatments that target microorganisms, whereas ter-
minal sterilization methods typically include irradia-
tion, ethylene oxide, or heat treatments and eliminate
all living microorganisms to a particular level of
assurance following treatment (Lambert et al. 2011).
Hundreds of thousands of tissue transplants are
performed globally each year. Musculoskeletal allo-
grafts (including bone, cartilage, tendons and liga-
ments typically used in orthopaedic procedures) are
the focus of a number of research groups aimed to
improve allograft patient outcomes (Saha and Roy
2013). Similar to other allografts, the risk of contam-
ination with dangerous pathogens is high, and safe
transplantation requires multiple processing consider-
ations (including aseptic tissue recovery and aseptic
tissue processing) in order to optimize allograft
recipient outcome. Musculoskeletal allografts have
the added benefit over cardiovascular allografts as
most musculoskeletal allografts are amenable to
terminal sterilization processes (Lambert et al.
2011). These sterilization methods typically remove
all biological components, but are more likely to
disrupt allograft structure and function. Bone allo-
grafts in particular are transplanted to provide struc-
tural integrity and growth factors to facilitate healing,
and are less susceptible to adverse effects from
terminal sterilization processes (Kamin´ski et al.
2009). Similarly, lower irradiation of tendon allografts
may have no adverse effect on its mechanical prop-
erties (Reid et al. 2010).
The purpose of this systematic review is to
determine the optimal methods of disinfection of
musculoskeletal tissue following recovery to mini-
mize the risk of disease transmission while maintain-
ing the structure and function of the tissue for its
intended use.
Methods
Information sources and search
The search strategy was developed and reviewed by
McMaster and the Musculoskeletal Tissue Processing
and Validation Subgroup (through SF). The electronic
databases MEDLINE and EMBASE were searched
from 1974 to May 29, 2014 using the following
headings and text words: ‘‘musculoskeletal system,’’
‘‘transplantation,’’ ‘‘bone transplantation,’’ ‘‘bone
marrow transplantation,’’ ‘‘cartilage transplantation,’’
and ‘‘anti-fungal agent.’’ An additional reviewer (AH)
performed a second search using the original search
strategy in the Pubmed database to include publica-
tions up to March 6, 2015. The search included
publications in English and excluded animal studies,
case reports, conference abstracts and patent literature.
The full search strategy is shown in Appendix A
(Electronic Supplementary Material).
Study selection
Seven reviewers (MW, SF, LT, MG, JT, GR, RP)
independently screened each of the citations in
duplicate to identify studies that met all of the
following inclusion criteria: (1) evaluated muscu-
loskeletal tissue (including bone, tendons, connective
tissue, cartilage, and muscle), (2) evaluated any
method during tissue processing to reduce bioburden,
and (3) evaluated bioburden, tissue viability or
transplantation results as outcomes. A study was
excluded if it was an animal study, a case report or an
editorial, letter, or review. If there was disagreement,
the full report was retrieved and independent assess-
ment was repeated until consensus was reached.
Data abstraction
Design of data abstraction forms and evidence
tables were guided by the questions in the analytic
framework [Appendix B (Electronic Supplementary
Material)] and approved and finalized by the
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musculoskeletal tissue subgroup (through SF). Four
reviewers (AD, DD, RB and DA) independently
abstracted the following study characteristics: first
author, year of publication, country, sample size,
donor, recovery site, tissues collected, pre-recovery
sanitization (environment and donor), amount and
type of recovered tissue, post-recovery storage condi-
tions, and preservation methods. The microbial sam-
ple testing method was summarized for each study.
Data collected for the outcomes included microbes
detected immediately following tissue recovery,
bioburden immediately following tissue recovery,
antimicrobial intervention following initial bioburden
assessment, incubation parameters, tissue integrity
and proportion of allografts discarded or potentially
discarded due to contamination as well as transplan-
tation outcomes where applicable. All data abstraction
was checked by the senior reviewers (AD and AG) to
ensure accuracy and consistency.
Quality assessment
Following the screening process, clinical studies that
met the eligibility criteria were evaluated for quality
using the Grades of Recommendation, Assessment,
Development, and Evaluation (GRADE) assessment.
The GRADE assessment analyzes a study’s limita-
tions, inconsistency of results, indirectness of evi-
dence, imprecision, and reporting bias and evaluates
the quality of its evidence, thus allowing for informed
recommendations (Guyatt et al. 2011). By systemat-
ically addressing multiple components that impact the
quality of evidence, the GRADE approach facilitates
criticism of the studies. There is no validated quality
assessment tool for laboratory-based studies because
basic science research is inherently considered level
IV, or low quality evidence (Balshem et al. 2011).
Data analysis
Data abstracted from all included studies were orga-
nized into tables presenting study characteristics,
culture methods, and outcomes. Descriptive statistics
included the frequency and percentage of bioburden
outcomes, as well as mean proportions. A meta-
analysis was not performed as there was high hetero-
geneity among the included clinical studies.
Results
Study selection
A total of 3377 citations were reviewed after dupli-
cates were removed (Fig. 1). Of the 3377 citations,
3270 were excluded because they did not fulfill the
screening criteria. The full text articles of the 105
citations were retrieved for further evaluation. Sixty-
six studies with a disinfection method and bioburden
or tissue integrity as an outcome were included. The
39 studies that were excluded and the reasons for
exclusion are provided in Appendix C (Electronic
Supplementary Material). Following the updated
search to include articles up to March 6, 2015, an
additional 324 articles were retrieved and 2 were
identified for further evaluation, and ultimately,
inclusion. A final number of 68 articles, including 56
laboratory studies and 12 clinical studies were there-
fore included in this review.
Quality of clinical studies
Of the 12 clinical reports, two studies performed
prospective, randomized clinical trials, and are cate-
gorized as providing level I evidence (Sun et al.
2009, 2011). Two prospective cohort and one ran-
domized trial were classified as level II evidence,
whereas the remaining seven reports performed retro-
spective chart reviews or cohort studies (level III
evidence) (Galia et al. 2009; Guo et al. 2012; Khoo
et al. 2006; Krasny et al. 2013; Pruss et al. 2002).
Using the GRADE assessment, the quality of clinical
studies according to the objectives was found to range
from very low to high. The clinical studies that
addressed bioburden reduction loads were of very low
quality. The clinical studies addressing terminal
sterilization methods with irradiation had an average
rating of low to moderate, whereas the one study
which evaluated the BioCleanseTM Tissue Steriliza-
tion Process was found to have a high quality rating.
The clinical studies that addressed the most effective
parameters for disinfecting bone during tissue pro-
cessing, as well as the patient outcomes related to use
of irradiated bone, had an average rating of low to
moderate for both of these findings. In relation to
patient outcomes related to use of irradiated tendons,
the relevant clinical studies were of moderate quality.
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Characteristics and culture methods of the studies
All included studies were conducted from 2000 to
2014, with the majority of laboratory studies con-
ducted in Europe (26/56 studies), North America (26/
56 studies), and the highest proportion of clinical
studies conducted in Asia (5/12). A total of 4372
musculoskeletal samples were used in 56 laboratory
studies, and 610 samples were used in 12 clinical
studies. Thirty-one studies utilized cadaveric tissue
and 8 studies used tissue recovered from organ donors.
The type of donor was not indicated in the remaining
32 studies.
Recovery of tissues was performed in operating
theatres for organ donors(Haimi et al. 2008; Schubert
et al. 2012) and autopsy rooms for cadaveric donors
(Lomas et al. 2004; Pruss et al. 2002), when reported.
Two studies indicated recovery of cadaveric tissues in
processing labs (Guo et al. 2012; Kaminski et al.
2012). Twelve studies indicated that during recovery,
allografts were recovered under aseptic conditions, but
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bioburden. Only one study reported the use of class C
and D air filters to reduce potential contamination of
tissues by airborne contaminant (Kaminski et al.
2012).
The majority of studies analyzed bone tissues
exclusively (35/68), whereas 14.7 % (10/68) of the
studies analyzed tendon, ligament and cartilage tissue.
Of these studies, researchers analyzed both bone and
tendons in 23 studies (32.4 %). Following recovery of
the tissue, saline and Hank’s Balanced salt solution
were the only reported solutions for short term storage.
Seven studies chose to preserve their tissue samples at
temperatures lower than -40 C.
Tissue samples may become contaminated before,
during or following recovery, which poses a threat to
the allograft recipient. Researchers used a variety of
techniques to determine the bioburden, or the amount
of contaminating microorganisms (bacteria, fungi, or
viruses). Culturing of sample swabs or of the sample
directly was used to detect bacteria and fungi in 15
laboratory studies, and two clinical studies. Growth
media for detection of bacteria and fungi were
extremely diverse and included Muller-Hinton agar,
soybean casein agar (also called tryptic soy agar),
tryptic soy broth, horse blood agar, Schaedler’s broth,
and Kanamycin-Esculin agar. The same media (blood
agar media), was used for both the detection of fungi
and bacteria in two studies. The detection of viruses
was performed by viral cell culture in 10 studies
(infection, and subsequent growth of infected cells
containing viruses). A microbiological assay to detect
the bioburden was not reported for 34 laboratory
studies, and 10 clinical studies. Incubation of bacterial
cultures between 30 and 37 C for 1–10 days were
reported in 16 studies.
Study outcomes
Bioburden and microbe identification
Prior to intervention, the contamination rate ranged
from 0 to 10.1 % in three studies that reported the
initial bioburden (Dunsmuir and Gallacher 2003;
Parker and Maschke 2008; Schubert et al. 2012). A
method to describe the cleaning of the musculoskeletal
allograft was reported in 32 laboratory studies, and six
clinical studies. Of the reported methods, mechanical
cleaning to remove additional tissue, and irrigation
were the most common methods of cleaning following
recovery. In six studies, chemical agents such as
dimethylformamide with Fmoc-[2-(2amino-ethoxy)-
ethoxy]-acetic acid, hydrogen peroxide, and chloro-
form–methanol solutions were used to remove addi-
tional soft tissue, such as fat or other debris from the
allografts. The contamination rate following tissue
cleaning was only reported in one study.
In Schubert et al. (2012), the presence of a number
of contaminating bacteria and fungi were observed.
These included species, in descending order of
prevalence, such as coagulase negative Staphylococ-
cus, Micrococcus, Bacillus cereus, Corynebacterium,
Penicilium, Alcaligenes, Lactobacillus, Eschericcia
coli, Acinetobacter, Enterococcus, Pseudomonas
aeruginosa, Pneumococcus, and the fungus, Candida.
These authors noted that of these species, Streptococ-
cus, Acinetobacter, and Escherichia are highly viru-
lent (Schubert et al. 2012). A number of studies
performed tests on tissues that were contaminated by
researchers following recovery to assess the efficacy
of their decontamination methods. Similar to the
recovered contaminating microorganisms observed in
Schubert et al. (2012), the most commonly inoculated
organisms in these studies were Staphylococci and
Bacillus species. Seven studies sought to test various
decontamination methods on tissues infected with
viruses, such as HIV2, pseudorabies virus (PRV),
bovine virus diarrhoea virus (BVD), hepatitis A virus
(HAV), and porcine parvovirus (PPV).
Bioburden reduction
For the laboratory studies, two studies were able to
eliminate all viruses and bacteria using peracetic acid
and ethanol soak for 2–4 h, and were effective in
reducing the logarithmic bioburden[4.19 to[8.23-
fold. This treatment revealed the greatest reduction in
bioburden compared to all other decontamination
methods. Parker and Maschke (2008) demonstrated
that pulsatile lavage of the allografts with a solution
containing polymyxin B (166.66 units/cc) and baci-
tracin (16.66 units/cc) reduced the logarithmic
bioburden by an average of 2.1 fold, whereas the
mechanical agitation or soaking in the same antibiotic
solution was only capable of reducing the logarithmic
bioburden by an average of [1.5 and 0.7-fold,
respectively.
In the clinical studies, the bioburden was only
addressed in one report. In Pruss et al. (2002),
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treatment of allografts with peracetic acid–ethanol
reduced the contamination rate to 0 %. The GRADE
quality of evidence for both studies were determined
to be very low. The remainder of the clinical studies
did not report the bioburden or contamination rate
following treatment.
Irradiation, peracetic acid, and BioCleanseTM Tis-
sue Sterilization Processes were used to treat the
allografts in the clinical studies.
In contrast to the disinfection methods, the majority
of papers utilized terminal sterilization methods to
reduce the bioburden. The greatest reduction in the
contamination rate was observed when samples were
irradiated at 25 kGy, or treated with ethylene oxide or
heat (82.5 C). When exposed to 25 kGy of irradia-
tion, three studies found that all bacteria and viruses
were eliminated (Baker et al. 2005; Hilmy et al. 2007;
Nguyen et al. 2011). At 30 kGy, the logarithmic viral
(HIV) bioburden reduction was 4.2 fold, but treatment
of samples with 50 kGy of irradiation followed by an
additional 30 kGy treatment resulted in the greatest
logarithmic reduction in bioburden ([8.2 fold log
reduction) (Hernigou et al. 2000). Irradiation at 800 W
for more than 2 min also reduced the viral contami-
nation rate to 0 % (Dunsmuir and Gallacher 2003).
One study was also able to eliminate all viruses
from contaminated bone samples using an ethylene
oxide treatment, reducing the logarithmic bioburden
by[5.3 fold (Moore et al. 2004). Heating of samples
at 82.5 C reduce the logarithmic viral bioburden by[
4.26 fold (Pruss et al. 2003b).
Tissue structural integrity
Irradiation was performed in 16 laboratory studies. In
the majority of the studies, treatment of the allografts
with less than 25 kGy did not affect the integrity of the
allograft. Irradiation temperature was reported in only
three studies, including -50, 30, 50, and 80 C (Grieb
et al. 2005; Hernigou et al. 2000; Pruss et al. 2002).
Researchers assessed a number of different variables,
including cyclic elongation and stiffness of the
tendons, or strength and elastic modulus, and failure
load acceptance of the bone allografts. At or above
25 kGy, the mechanical effects are varied, but in
general, there is a dose-dependent effect, with increas-
ing irradiation dosages. Seven studies showed that
there was a reduction in tensile strength (acoustic
emission), maximum force, and deformation energy
with exposure to large doses of irradiation ([35 kGy).
Interestingly, two studies showed an increase in
ultimate strain, Young’s modulus, and strain energy
density or the resilience and elastic limit of bones,
following irradiation at 18–50 kGy, and 35 kGy,
respectively (Grieb et al. 2005; Kaminski et al. 2012).
Tissue viability following treatment with ethylene
oxide was addressed in one report. Lomas et al. (2001)
reported that this treatment with aeration eliminated
all viruses, but induced production of the inflammation
cytokines, TNF-a and IL-6. To reduce cytokine
induction, the researchers disinfected the allograft
with ethylene oxide without aeration, and were still
able to achieve full disinfection of the allograft
(Lomas et al. 2001). Treatment without aeration is
more likely to cause physiological issues due to the
residual ethylene oxide (Lomas et al. 2001). Tissue
viability was not assessed directly following the use of
other chemicals to disinfect the allografts.
Transplantation outcomes
Prior to release for transplantation, a portion of
allografts from the donor are tested to ensure that
they are free of bacteria. Of the clinical studies, eight
reports utilized a total of 606 irradiated allografts for
transplantation, and most studies disinfected the
samples using 25, 35, or 50 kGy of irradiation. Of
these, eight transplanted allografts were found to be
infected following transplantation (1.3 %). The source
of the infection was not stated. One was resolved by
treatment with antibiotics, and another required
amputation (Khoo et al. 2006). The GRADE quality
of the clinical evidence was low to moderate.
Of the remaining studies, 43 BioCleanseTM Tissue
Sterilization Processed allografts, 154 antibiotic-
treated allografts, and 3087 peracetic acid–ethanol
treated allografts were transplanted into patients
(Indelicato et al. 2013; Pruss et al. 2002). No recipients
experienced any primary infections as a result of
contaminated allografts from the BioCleanseTM or
peracetic acidethanol-treated allografts; however, nine
peracetic acid–ethanol treated transplant recipients did
experience secondary infections (Indelicato et al.
2013; Pruss et al. 2002). Approximately 3.9 % of
patients (6/154) receiving the antibiotic-treated allo-
grafts developed primary deep wound infections. The
source of the infections were not stated. The GRADE
578 Cell Tissue Bank (2016) 17:573–584
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quality of the BioCleanseTM Sterilization Process
studies was high.
In addition to primary outcomes regarding infection
rate in transplant recipients, three studies also
addressed secondary outcomes as a result of irradia-
tion at 25 kGy (Guo et al. 2012; Sun et al. 2009, 2011).
Performing comparison of irradiated to non-irradiated
allografts, recipients with irradiated allografts report
more anterior laxity, and significant differences in the
Lachman test, ADT, pivot shift test, and instrumented
KT-2000 arthrometer tests. The GRADE quality of
evidence, regarding the tendon and bone integrity was
rated as low to moderate for the studies in bone, and
moderate for the tendon analysis. The remainder of the
studies reported no significant differences in sec-
ondary outcomes or did not report secondary outcomes
at all.
Confounding effects
The use of antibiotics, irradiation, and chemical
sterilization have greatly improved the number of
recovered musculoskeletal allografts available to
patients. However, it is difficult to assess the efficacy
of the majority of these methods, without baseline
indicators, such as the initial bioburden or contami-
nation rate following recovery. A limited number of
reports have addressed this by quantifying bioburden,
and representing the logarithmic reduction in biobur-
den in the results. Similarly, a number of studies report
methods to clean the allografts following recovery.
Without measurements prior to, and immediately
following these methods, it is difficult to assess the
best practices to clean allografts following recovery.
An additional confounding effect is the diverse
number of parameters for the reported decontamina-
tion methods. For example, the majority of reports
utilized irradiation at doses between 0.05 and
630 kGy. This extensive range allows for direct
comparisons between irradiation dosages, but this
was rarely addressed for other processing methods,
such as the effect of temperature on disinfection
efficiency.
Discussion
The incidence of musculoskeletal allograft contami-
nation can be as high as 10.1 %, and the studies in this
review demonstrated a number of methods to address
this issue. It was found that incubation of tissues in
peracetic acid–ethanol for 4 h resulted in the greatest
reduction in bioburden. Irradiation with 25 kGy was
the most common method of terminal sterilization,
and was effective in bioburden reduction, with min-
imal negative impact on tissue structural integrity.
Most studies reported the long term preservation of
allografts below -40 C, and transplantation of
irradiated, peracetic acid and ethanol-treated, or
BioCleanseTM Tissue Sterilization Processed allo-
grafts resulted in no adverse events related to
contamination.
Following recovery, the allografts often need to be
cleaned to remove extraneous tissues. A number of
studies reported cleaning processes to remove addi-
tional tissues, but bioburden was not assessed follow-
ing cleaning.
All studies employed a method to disinfect the
allografts. The most effective method to disinfect the
tissue was chemical sterilization with peracetic acid–
ethanol treatment. Following a 4 h incubation, obser-
vers reported the presence of almost no viral or
bacterial contaminants, reducing the contamination
rate to 0 %. One study reported that peracetic acid
ethanol treatment had no effect on the presence of
hepatitis A virus, suggesting that this species, or
possibly even all hepatoviruses may be resistant to
peracetic acid–ethanol treatment (Pruss et al. 2003a).
Other methods, such as antibiotic treatment or
BioCleanseTM Tissue Sterilization Processing of the
allografts were able to reduce bioburden, but were not
as effective as percetic acid–ethanol treatment, when
reported. It should be noted that while the use of
antibiotics to soak the allografts was relatively effec-
tive in bioburden reduction, the use of pulsatile lavage
using the same antibiotic-containing solution expo-
nentially increased the reduction in bioburden. The
details regarding the flow rate and method of pulsatile
lavage were not reported, and its effectiveness in
reducing bioburden may be increased with optimiza-
tion of the protocol.
A number of reports opted to use terminal steril-
ization methods to reduce the bioburden. The most
commonly reported method was irradiation. Both
gamma irradiation and electron beam irradiation were
used, and showed similar capacities in both bioburden
reduction and maintenance of tissue following treat-
ment. The greatest logarithmic reduction in bioburden
Cell Tissue Bank (2016) 17:573–584 579
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([8.2 fold) was observed when samples were exposed
to 50 kGy of irradiation (Grieb et al. 2005). Although
the studies addressed a wide range of radiation
dosages, the majority of studies with effective reduc-
tion of bioburden with minimal effect on the allograft
viability utilized a dosage ranging from 18 to 35 kGy.
Heat treatments were relatively ineffective at
decontamination relative to irradiation and ethylene
oxide treatment. Ethylene oxide (214 mg/dl) exposure
at 25 C for 4 h was able to completely eliminate the
contamination rate to 0 % (Moore et al. 2004).
Although tissue viability was not monitored at
25 C, increasing the treatment temperature to 37 C
was also effective in decontamination and did not
induce cytokine induction when aeration was
excluded from the protocol (Lomas et al. 2001).
Terminal sterilization is not typically used for non-
musculoskeletal allografts, as they may affect tissue
integrity. Three studies revealed that irradiation results
in significant differences in multiple tests to assay
transplant function in the recipient. These include the
Lachman test, ADT, pivot shift test, and instrumented
KT-2000 arthrometer test (Guo et al. 2012; Sun et al.
2009, 2012). Peracetic acid–ethanol was used in one
study to disinfect allografts, and posttransplantation
assays revealed good clinical outcomes for all recip-
ients (Pruss et al. 2002).
Limitations
In this systematic review, the most effective methods
of musculoskeletal allograft decontamination were
assessed. As previously stated, 56 studies were
laboratory studies and are not amenable to GRADE
analysis. However, 12 clinical studies were included,
and were evaluated for their level of evidence. Seven
studies provided level III evidence, which are not
typically used to formulate clinical recommendations.
As clinical reports are usually formulated based on
level I and II evidence.
The contamination rate and logarithmic bioburden
reduction outcomes were utilized to determine the
most effective methods of decontamination. There
was a large amount of heterogeneity in the culturing
methods to determine both of these values. Some
organisms are extremely fastidious, and may only
grow within a narrow range of nutrient and environ-
mental conditions. Most studies used media types that
are proposed to be able to capture the majority of
organisms that may contaminate the tissues, but the
use of only one culturing media, or incubation
parameter could possibly exclude important pathogens
that would affect transplantation outcomes. There was
also a lack of data regarding clinical outcomes which
were sought to address in this review.
The initial bioburden was reported in only one
study, and as such, it is difficult to assess the best pre-
recovery precautionary measures, or allograft cleaning
methods to reduce bioburden. Additionally, the num-
ber of decontamination methods discussed was
extremely diverse, but the reports failed to address a
number of parameters that could affect positive
outcomes following decontamination. One exception
was the use of irradiation, which was comprehensively
examined among the reports. Testing of irradiation to
disinfect tissues featured a broad range of radiation
dosages, as well as incubation conditions that allow for
informed conclusions.
Antibiotics were used to disinfect allografts in three
studies (Parker and Maschke 2008; Saegeman et al.
2009; Schubert et al. 2012). Although a number of
different antibiotics were used, incubation conditions
were similar within studies. This allows for direct
comparisons of other factors, but may not necessarily
represent optimal conditions for disinfection. Parker
and Maschke (2008) was the only study that reported
quantitative bioburden levels following treatment, as
well as addressing different methods of administering
antibiotics to allografts.
A similar trend was observed for chemical disin-
fection of the allografts. Chlorhexidine was used to
disinfect tissues at concentrations ranging from 0.2 to
10 %. At higher concentrations, there was a corre-
sponding increase in the number of samples that were
free from contamination. However, there were no
assays of tissue integrity, viability, or transplantation
outcomes that suggest its safety or efficacy in
preserving tissue integrity (Hernigou et al. 2000;
Saegeman et al. 2009; Schubert et al. 2012). When
samples were treated with ethylene oxide, there was a
much narrower range of different conditions tested,
but tissue integrity was assessed, which could also
provide insight into protocol optimization (Bienek
et al. 2007; Lomas et al. 2001; Moore et al. 2004).
Five laboratory studies and one clinical study opted
to test the efficacy of the BioCleanseTM Tissue
Sterilization Process. The use of this system was
extremely effective in reducing the bioburden, and did
580 Cell Tissue Bank (2016) 17:573–584
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not have any reported adverse effects on the tissue
integrity or transplantation outcomes. The product and
process is patented, and therefore does not allow for
programs to adopt without licensing the technology.
Finally, a large proportion of the studies did not
address the bioburden reduction capabilities of the
disinfection methods used. In 13 laboratory studies
and one clinical study, the reduction in bioburden as a
result of the disinfection process was reported. As
opposed to the contamination rate, the reduction in
bioburden value can quantitatively show the effec-
tiveness of disinfection methods, and allows for
further optimization.
Conclusions
The results of this review suggest that the use of
peracetic acid–ethanol for 4 h, or terminal sterilization
methods such as irradiation (\25 kGy), results in the
greatest quantitative reduction in bioburden, with
minimal effects on tissue viability and transplantation
outcomes, BioCleanseTM Tissue Sterilization Process-
ing demonstrated significant qualitative reduction in
bioburden with minimal effects on tissue viability and
transplantation outcomes. Long term storage of mus-
culoskeletal allografts is often through freezing at
temperatures below -40 C. A limited number of
reports suggest that pulsatile lavage with antibiotic
solutions, or treatment with ethylene oxide or
chlorhexidine may also be an effective method of
bioburden reduction following optimization of these
processes
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